Comparative Pharmacology
Head-to-head clinical analysis: DROSPIRENONE ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM versus FEMRING.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DROSPIRENONE ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM versus FEMRING.
DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM vs FEMRING
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Combination of drospirenone (a progestin with antimineralocorticoid and antiandrogenic activity), ethinyl estradiol (an estrogen), and levomefolate calcium (a folate supplement). Prevents ovulation by suppressing gonadotropins; increases cervical mucus viscosity, inhibiting sperm penetration; levomefolate provides folate to reduce neural tube defect risk.
Femring (estradiol acetate) is a vaginal ring that releases estradiol, which binds to estrogen receptors (ERα and ERβ) in target tissues, regulating gene transcription and exerting estrogenic effects on the vaginal epithelium, urogenital tract, and other estrogen-sensitive tissues.
One tablet orally once daily for 28 days (21 active tablets containing drospirenone 3 mg, ethinyl estradiol 0.02 mg, and levomefolate calcium 0.451 mg, followed by 7 placebo tablets containing levomefolate calcium 0.451 mg).
Insert one vaginal ring containing 0.05 mg or 0.10 mg estradiol acetate per day; replace every 3 months.
None Documented
None Documented
Drospirenone: ~30 hours (steady state achieved after 8 days). Ethinyl estradiol: ~13-17 hours (biphasic, terminal). Levomefolate calcium: ~4-6 hours (folate derivatives have longer retention).
The terminal elimination half-life of estradiol from the vaginal ring (Femring) is approximately 36 hours. This extended half-life supports once-monthly dosing and maintains steady-state concentrations.
Drospirenone: ~50% renal (as metabolites), ~40% fecal. Ethinyl estradiol: ~40% renal, ~60% fecal. Levomefolate calcium: ~70% renal (as folate metabolites), ~30% fecal.
Estradiol is primarily excreted in urine (about 90-95%) as conjugated metabolites (glucuronides and sulfates), with approximately 5-10% eliminated in feces via bile. Less than 5% is excreted unchanged.
Category D/X
Category C
Progestin + Estrogen
Estrogen